The United States’ top biomedical research agency has halted payments to research groups abroad, jeopardizing multi-million-dollar research projects on cancer, viral infections, and human genetics around the world.
The United States’ top biomedical research agency has halted payments to research groups abroad, jeopardizing multi-million-dollar research projects on cancer, viral infections, and human genetics around the world.